De novo SCN2A splice site mutation in a boy with Autism spectrum disorder
- PMID: 24650168
- PMCID: PMC3994485
- DOI: 10.1186/1471-2350-15-35
De novo SCN2A splice site mutation in a boy with Autism spectrum disorder
Abstract
Background: SCN2A is a gene that codes for the alpha subunit of voltage-gated, type II sodium channels, and is highly expressed in the brain. Sodium channel disruptions, such as mutations in SCN2A, may play an important role in psychiatric disorders. Recently, de novo SCN2A mutations in autism spectrum disorder (ASD) have been identified. The current study characterizes a de novo splice site mutation in SCN2A that alters mRNA and protein products.
Case presentation: We describe results from clinical and genetic characterizations of a seven-year-old boy with ASD. Psychiatric interview and gold standard autism diagnostic instruments (ADOS and ADI-R) were used to confirm ASD diagnosis, in addition to performing standardized cognitive and adaptive functioning assessments (Leiter-R and Vineland Adaptive Behavior Scale), and sensory reactivity assessments (Sensory Profile and Sensory Processing Scales). Genetic testing by whole exome sequencing revealed four de novo events, including a splice site mutation c.476 + 1G > A in SCN2A, a missense mutation (c.2263G > A) causing a p.V755I change in the TLE1 gene, and two synonymous mutations (c.2943A > G in the BUB1 gene, and c.1254 T > A in C10orf68 gene). The de novo SCN2A splice site mutation produced a stop codon 10 amino acids downstream, possibly resulting in a truncated protein and/or a nonsense-mediated mRNA decay. The participant met new DSM-5 criteria for ASD, presenting with social and communication impairment, repetitive behaviors, and sensory reactivity issues. The participant's adaptive and cognitive skills fell in the low range of functioning.
Conclusion: This report indicates that a splice site mutation in SCN2A might be contributing to the risk of ASD. Describing the specific phenotype associated with SCN2A mutations might help to reduce heterogeneity seen in ASD.
Figures

Similar articles
-
Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.Epilepsia. 2014 Apr;55(4):e25-9. doi: 10.1111/epi.12554. Epub 2014 Mar 1. Epilepsia. 2014. PMID: 24579881 Review.
-
De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies.Neurology. 2009 Sep 29;73(13):1046-53. doi: 10.1212/WNL.0b013e3181b9cebc. Neurology. 2009. PMID: 19786696 Free PMC article.
-
De novo mutations revealed by whole-exome sequencing are strongly associated with autism.Nature. 2012 Apr 4;485(7397):237-41. doi: 10.1038/nature10945. Nature. 2012. PMID: 22495306 Free PMC article.
-
Scn2a severe hypomorphic mutation decreases excitatory synaptic input and causes autism-associated behaviors.JCI Insight. 2021 Aug 9;6(15):e150698. doi: 10.1172/jci.insight.150698. JCI Insight. 2021. PMID: 34156984 Free PMC article.
-
Decoding SCN2A Variants: Bridging Genetics and Phenotypes in Autism Spectrum Disorder.J Clin Med. 2025 May 28;14(11):3790. doi: 10.3390/jcm14113790. J Clin Med. 2025. PMID: 40507552 Free PMC article. Review.
Cited by
-
SCN2A mutation in an infant with Ohtahara syndrome and neuroimaging findings: expanding the phenotype of neuronal migration disorders.J Genet. 2019 Jun;98(2):54. J Genet. 2019. PMID: 31204721
-
Differential Modulation of the Voltage-Gated Na+ Channel 1.6 by Peptides Derived From Fibroblast Growth Factor 14.Front Mol Biosci. 2021 Sep 7;8:742903. doi: 10.3389/fmolb.2021.742903. eCollection 2021. Front Mol Biosci. 2021. PMID: 34557523 Free PMC article.
-
Using Zebrafish to Model Autism Spectrum Disorder: A Comparison of ASD Risk Genes Between Zebrafish and Their Mammalian Counterparts.Front Mol Neurosci. 2020 Nov 11;13:575575. doi: 10.3389/fnmol.2020.575575. eCollection 2020. Front Mol Neurosci. 2020. PMID: 33262688 Free PMC article. Review.
-
Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases.Nat Genet. 2017 Apr;49(4):515-526. doi: 10.1038/ng.3792. Epub 2017 Feb 13. Nat Genet. 2017. PMID: 28191889 Free PMC article.
-
Estimating the Prevalence of De Novo Monogenic Neurodevelopmental Disorders from Large Cohort Studies.Biomedicines. 2022 Nov 9;10(11):2865. doi: 10.3390/biomedicines10112865. Biomedicines. 2022. PMID: 36359385 Free PMC article.
References
-
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5. Arlington, VA: American Psychiatric Publishing; 2013.
-
- Neale BM, Kou Y, Liu L, Ma'ayan A, Samocha KE, Sabo A, Lin CF, Stevens C, Wang LS, Makarov V, Polak P, Yoon S, Maguire J, Crawford EL, Campbell NG, Geller ET, Valladares O, Schafer C, Liu H, Zhao T, Cai G, Lihm J, Dannenfelser R, Jabado O, Peralta Z, Nagaswamy U, Muzny D, Reid JG, Newsham I, Wu Y. et al.Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature. 2012;15(7397):242–245. doi: 10.1038/nature11011. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous